Vor Biopharma Inc.
Net SellingVOR·US·🇺🇸 US
9%buys·91%sells
571 transactions$274.5MTotal buys·24 buys
$237.8MTotal sells·233 sells
3636 insiders
Last: Dec 18, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 15, 26 | Shah Rajeev M. | Sell | $859K | |
| Apr 15, 26 | Kolchinsky Peter | Sell | $859K | |
| Apr 15, 26 | RA Capital Healthcare Fund LP | Sell | $859K | |
| Apr 15, 26 | RA CAPITAL MANAGEMENT, L.P. | Sell | $859K | |
| Apr 14, 26 | Shah Rajeev M. | Sell | $2.5M | |
| Apr 14, 26 | Kolchinsky Peter | Sell | $2.5M | |
| Apr 14, 26 | RA Capital Healthcare Fund LP | Sell | $2.5M | |
| Apr 14, 26 | RA CAPITAL MANAGEMENT, L.P. | Sell | $2.5M | |
| Apr 13, 26 | Shah Rajeev M. | Sell | $8.6M | |
| Apr 13, 26 | Kolchinsky Peter | Sell | $8.6M |
Vor Biopharma Inc. is seeing coordinated insider selling. 4 insiders sold shares in the last 30 days, with total sell volume of $30.4M. Overall insider sentiment is bearish (91% sales).
Vor Biopharma Inc. (VOR) has recorded 571 insider operations, including 24 open-market purchases ($274.5M), 233 sales ($237.8M) and 314 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (91% sales).
Insider activity at Vor Biopharma Inc. is sustained, with operations recorded in 8 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are ANG ROBERT (CEO), Kress Jean-Paul (CEO) & Mahatme Sandesh (CFO), with respectively 43, 8, 116 transactions.
Across all 619 recorded transactions, the breakdown by type is: sells (281, 45%), grant (144, 23%), exercise (76, 12%), tax (65, 11%), buys (24, 4%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Vor Biopharma Inc. has recorded 571 insider operations in total, including 24 open-market purchases ($274.5M), 233 sales ($237.8M) and 314 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 18, 2025.
Insiders at Vor Biopharma Inc. are currently net sellers, with 9% purchases and 91% sales across all reported transactions. Total buy volume is $274.5M versus $237.8M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 36 insiders at Vor Biopharma Inc. (VOR). ANG ROBERT (CEO, 43 tx), Kress Jean-Paul (CEO, 8 tx), Mahatme Sandesh (CFO, 116 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for VOR is bearish, based on a 9% buy ratio across 257 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Vor Biopharma Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.